BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17960611)

  • 21. [Relationship between human papillomavirus 16 infection and the expression of p33(ING1b), human telomerase reverse transcriptase in cervical squamous cell carcinoma of Uygur female in Xinjiang Uygur Autonomous Region].
    Mayinuer N; Liu F; Zhu KC; Dai JX; Ayeti S; Wang L; Kunduozi U
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):592-6. PubMed ID: 18051711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas.
    Zhang A; Zheng C; Hou M; Lindvall C; Wallin KL; Angström T; Yang X; Hellström AC; Blennow E; Björkholm M; Zetterberg A; Gruber A; Xu D
    Genes Chromosomes Cancer; 2002 Jul; 34(3):269-75. PubMed ID: 12007187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
    Li F; Cui J
    Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women.
    Lin ZH; Shen XH; Jin Z; Kim Y; Lee E; Kim H; Kim I
    Pathol Int; 2005 Aug; 55(8):491-6. PubMed ID: 15998377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.
    Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M
    Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative determination of human telomerase reverse transcriptase messenger RNA expression in premalignant cervical lesions and correlation with human papillomavirus load.
    Oikonomou P; Mademtzis I; Messinis I; Tsezou A
    Hum Pathol; 2006 Feb; 37(2):135-42. PubMed ID: 16426912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.
    DeCarlo CA; Severini A; Edler L; Escott NG; Lambert PF; Ulanova M; Zehbe I
    Lab Invest; 2010 Oct; 90(10):1482-91. PubMed ID: 20479716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer.
    Espinosa AM; Alfaro A; Roman-Basaure E; Guardado-Estrada M; Palma Í; Serralde C; Medina I; Juárez E; Bermúdez M; Márquez E; Borges-Ibáñez M; Muñoz-Cortez S; Alcántara-Vázquez A; Alonso P; Curiel-Valdez J; Kofman S; Villegas N; Berumen J
    PLoS One; 2013; 8(2):e55975. PubMed ID: 23405241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection.
    Zejnullahu VA; Zejnullahu VA; Josifovska S; Vukovik N; Pakovski K; Panov S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Dec; 38(3):143-151. PubMed ID: 29668478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
    Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
    Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the hTERT expression in squamous cell cervical carcinoma is not associated with gene amplification.
    Anedchenko E; Oparina N; Dmitriev A; Krasnov G; Pavlova L; Alexandrova N; Kisseljov F; Senchenko V
    Oncol Rep; 2008 Aug; 20(2):469-74. PubMed ID: 18636213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hTERT Protein Expression in Cytoplasm and Nucleus and its Association With HPV Infection in Patients With Cervical Cancer.
    Moreno-Acosta P; Molano M; Morales N; Acosta J; GonzÁlez-Prieto C; Mayorga D; Buitrago L; Gamboa O; MejÍa JC; Castro J; Romero-Rojas A; Espenel S; Murray GL; Garland SM; Vallard A; MagnÉ N
    Cancer Genomics Proteomics; 2020; 17(5):615-625. PubMed ID: 32859640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
    Kailash U; Soundararajan CC; Lakshmy R; Arora R; Vivekanandhan S; Das BC
    Br J Cancer; 2006 Nov; 95(9):1250-7. PubMed ID: 17060942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells.
    Vazquez-Ortiz G; García JA; Ciudad CJ; Noé V; Peñuelas S; López-Romero R; Mendoza-Lorenzo P; Piña-Sánchez P; Salcedo M
    Int J Gynecol Cancer; 2007; 17(2):484-91. PubMed ID: 17309674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis.
    Bierkens M; Krijgsman O; Wilting SM; Bosch L; Jaspers A; Meijer GA; Meijer CJ; Snijders PJ; Ylstra B; Steenbergen RD
    Genes Chromosomes Cancer; 2013 Jan; 52(1):56-68. PubMed ID: 22987659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
    Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
    J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer.
    Wan F; Miao X; Quraishi I; Kennedy V; Creek KE; Pirisi L
    Int J Cancer; 2008 Jul; 123(1):32-40. PubMed ID: 18398830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Syrjänen S; Favalli C; Syrjänen K;
    Acta Cytol; 2006; 50(1):6-15. PubMed ID: 16514834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers in cervical screening: quantitative reverse transcriptase PCR analysis of P16INK4a expression.
    Boulet GA; Horvath CA; Depuydt CE; Bogers JJ
    Eur J Cancer Prev; 2010 Jan; 19(1):35-41. PubMed ID: 19910796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions.
    Oikonomou P; Messinis I; Tsezou A
    Exp Biol Med (Maywood); 2007 Jul; 232(7):881-6. PubMed ID: 17609503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.